A Controlled, Parallel Group, Open-label, Multi-Center Extension Study to Investigate Efficacy and Safety of Oral BAY 85-3934 and Active Comparator (epoetin afla/beta)in the Long-term Treatment of subjects with Anemia Associated with Chronic Kidney Disease
Investigator
Mandip Panesar, MD Principal Investigator
Wnnie Su, MD Sub-Investigator